Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING (Tables)

v3.21.2
SEGMENT REPORTING (Tables)
 6 Months Ended
Jun. 30, 2021
Segment Reporting [Abstract]  
SCHEDULE OF INFORMATION ABOUT REPORTED SEGMENT PROFIT OR LOSS AND ASSETS

 

    Breast           COVID-19        
    Cancer Test     Alzheimer     Testing     Total  
Six months ended June 30, 2021                                
Revenues     -                     -       6,763       6,763  
Operating loss     (2,977 )     -       (213 )     (3,190 )
Unallocated amounts:                                
Financing expenses, net                             (10,485 )
Share in losses of affiliated companies accounted for under equity method, net                             (492 )
Net loss                             (14,167 )
Total Assets     11,029       -       6,229       17,258  
Other significant items:                                
Total expenditures for assets of reportable segment     -       -       770       770  
Total depreciation for reportable segment     (15 )     -       (341 )     (356 )
SUMMARY OF REVENUES BY GEOGRAPHIC REGION

 

   

Six months
period ended

June 30,

    

Three months
period ended

June 30,

    

Year ended
December 31,

 
    2021     2021     2020  
    Unaudited  
                   
Israel   $ -     $ -       -  
United States     6,763       1,732                 -  
      6,763       1,732       -  
SUMMARY OF PROPERTY AND EQUIPMENT, NET, BY GEOGRAPHIC AREA

   

As of
June 30,

    As of
December 31,		  
    2021     2020  
Israel   $ 47     $ 61  
United States     2,549       1,938  
    $ 2,596     $ 1,999